Steller Consulting

We provide guidance for biotechnology and pharmaceutical companies on the identification of novel drug targets and early-stage compound development for the treatment of cancer and age-related neurodegenerative diseases. Our specific expertise is in the area of cell death research (apoptosis) and regulated protein degradation. Prof. Hermann Steller is the Strang Professor at The Rockefeller University and has over 30 years of experience as a leader in academic science.